Paclitaxel | Antitumor Agent | MedChemExpress
Optimising dose-dense regimens for early breast cancer | Cancer World Archive
JPM | Free Full-Text | Immunotherapy for Squamous Esophageal Cancer: A Review
12x Chemo, eisgekühlt bitte! Neuer Wirkstoff Paclitaxel
IOLite: phase 1b trial of doublet/triplet combinations of dostarlimab with niraparib, carboplatin–paclitaxel, with or without bevacizumab in patients with advanced cancer | Journal for ImmunoTherapy of Cancer
Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer | NEJM
IJERPH | Free Full-Text | Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin as the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer
Mammakarzinom: 4x AC + 12x Paclitaxel anstelle von 4x EC + 12x Paclitaxel
Cancers | Free Full-Text | Eribulin and Paclitaxel Differentially Alter Extracellular Vesicles and Their Cargo from Triple-Negative Breast Cancer Cells
12x Chemo, eisgekühlt bitte! Neuer Wirkstoff Paclitaxel
Approved for use in:
Mechanisms for the transport and accumulation of albumin-bound... | Download Scientific Diagram
IJMS | Free Full-Text | Paclitaxel Induces Apoptosis in Breast Cancer Cells through Different Calcium—Regulating Mechanisms Depending on External Calcium Conditions
12x Chemo, eisgekühlt bitte! Neuer Wirkstoff Paclitaxel
Chemo Ende, neue Haare und ein Schockmoment!
JCM | Free Full-Text | Current Treatment Landscape for Early Triple-Negative Breast Cancer (TNBC)
Paclitaxel (Taxol) upregulates expression of functional interleukin-6 in human ovarian cancer cells through multiple signaling pathways | Oncogene
Breast Pathway Group – EC x 4 – Accelerated Paclitaxel x 4: Epirubicin & Cyclophosphamide x 4 followed by Accelerated Pa
